-
1
-
-
0028575453
-
A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index
-
Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21:2286-2291.
-
(1994)
J Rheumatol
, vol.21
, pp. 2286-2291
-
-
Garrett, S.1
Jenkinson, T.2
Kennedy, L.G.3
-
2
-
-
24944444407
-
Measuring disease activity in ankylosing spondylitis: Patient and physician have different perspectives
-
DOI 10.1093/rheumatology/keh595
-
Spoorenberg A, van Tubergen A, Landewe R, et al. Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford) 2005; 44:789-795. (Pubitemid 41487211)
-
(2005)
Rheumatology
, vol.44
, Issue.6
, pp. 789-795
-
-
Spoorenberg, A.1
Van Tubergen, A.2
Landewe, R.3
Dougados, M.4
Van Der Linden, S.5
Mielants, H.6
Van De Tempel, H.7
Van Der Heijde, D.8
-
3
-
-
1842680174
-
The Influence of Peripheral Arthritis on Disease Activity in Ankylosing Spondylitis Patients as Measured with the Bath Ankylosing Spondylitis Disease Activity Index
-
Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, et al. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum 2004; 51:154-159. (Pubitemid 38468696)
-
(2004)
Arthritis Care and Research
, vol.51
, Issue.2
, pp. 154-159
-
-
Heuft-Dorenbosch, L.1
Van Tubergen, A.2
Spoorenberg, A.3
Landewe, R.4
Dougados, M.5
Mielants, H.6
Van Der Tempel, H.7
Van Der Heijde, D.8
-
4
-
-
70449721120
-
Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations
-
Song IH, Rudwaleit M, Listing J, et al. Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations. Ann Rheum Dis 2009; 68: 1701-1707.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1701-1707
-
-
Song, I.H.1
Rudwaleit, M.2
Listing, J.3
-
5
-
-
33751280739
-
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis
-
DOI 10.1136/ard.2005.042630
-
Pham T, Landewe R, van der Linden S, et al. An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis. Ann Rheum Dis 2006; 65:1620-1625. (Pubitemid 44799675)
-
(2006)
Annals of the Rheumatic Diseases
, vol.65
, Issue.12
, pp. 1620-1625
-
-
Pham, T.1
Landewe, R.2
Van Der Linden, S.3
Dougados, M.4
Sieper, J.5
Braun, J.6
Davis, J.7
Rudwaleit, M.8
Collantes, E.9
Burgos-Vargas, R.10
Edmonds, J.11
Olivieri, I.12
Van Der Horst-Bruinsma, I.13
Mielants, H.14
Stone, M.15
Emery, P.16
Van Der Heijde, D.17
-
6
-
-
58349090431
-
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis
-
Lukas C, Landewe R, Sieper J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68:18-24.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 18-24
-
-
Lukas, C.1
Landewe, R.2
Sieper, J.3
-
7
-
-
0032915527
-
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis
-
Spoorenberg A, van der Heijde D, de Klerk E, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999; 26:980-984. (Pubitemid 29195698)
-
(1999)
Journal of Rheumatology
, vol.26
, Issue.4
, pp. 980-984
-
-
Spoorenberg, A.1
Van Der Heijde, D.2
De Klerk, E.3
Dougados, M.4
De Vlam, K.5
Mielants, H.6
Van Der Tempel, H.7
Van Der Linden, S.8
-
8
-
-
72249090182
-
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis
-
Van der Heijde D, Lie E, Kvien TK, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68:1811-1818.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1811-1818
-
-
Van Der Heijde, D.1
Lie, E.2
Kvien, T.K.3
-
9
-
-
23644434603
-
The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: A six-month, longitudinal, observational, multicenter study
-
DOI 10.1002/art.21209
-
Heiberg MS, Nordvag BY, Mikkelsen K, et al. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study. Arthritis Rheum 2005; 52: 2506-2512. (Pubitemid 41117438)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.8
, pp. 2506-2512
-
-
Heiberg, M.S.1
Nordvag, B.-Y.2
Mikkelsen, K.3
Rodevand, E.4
Kaufmann, C.5
Mowinckel, P.6
Kvien, T.K.7
-
10
-
-
79958857590
-
Endorsement of the definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score (ASDAS): Results from the Outcome Measures in Rheumatology (OMERACT) 10 conference
-
in press
-
Machado P, Landewe R, van der Heijde D. Endorsement of the definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score (ASDAS): results from the Outcome Measures in Rheumatology (OMERACT) 10 conference. J Rheumatol (in press).
-
J Rheumatol
-
-
MacHado, P.1
Landewe, R.2
Van Der Heijde, D.3
-
11
-
-
78650657046
-
Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining cut-off values for disease activity states and improvement scores
-
Machado P, Landewe R, Lie E, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 2011; 70:47-53.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 47-53
-
-
MacHado, P.1
Landewe, R.2
Lie, E.3
-
12
-
-
77953710657
-
Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors
-
Pedersen SJ, Sorensen IJ, Hermann KG, et al. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 2010; 69:1065-1071.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1065-1071
-
-
Pedersen, S.J.1
Sorensen, I.J.2
Hermann, K.G.3
-
13
-
-
77955386556
-
Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis
-
Nas K, Yildirim K, Cevik R, et al. Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis. Int J Rheum Dis 2010; 13:240-245.
-
(2010)
Int J Rheum Dis
, vol.13
, pp. 240-245
-
-
Nas, K.1
Yildirim, K.2
Cevik, R.3
-
14
-
-
78650581154
-
Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: A prospective, follow-up of disease activity assessment in ankylosing spondylitis
-
Aydin SZ, Can M, Atagunduz P, et al. Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis. Clin Exp Rheumatol 2010; 28:752-755.
-
(2010)
Clin Exp Rheumatol
, vol.28
, pp. 752-755
-
-
Aydin, S.Z.1
Can, M.2
Atagunduz, P.3
-
15
-
-
78649749326
-
Is ASDAS better than BASDAIasameasureof disease activity in axial psoriatic arthritis?
-
Eder L, Chandran V, Shen H, et al. Is ASDAS better than BASDAIasameasureof disease activity in axial psoriatic arthritis? Ann Rheum Dis 2010; 69:2160-2164.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 2160-2164
-
-
Eder, L.1
Chandran, V.2
Shen, H.3
-
16
-
-
79958781492
-
Evaluation of the newASAS instrument to assess disease activity, the ASDAS, in patients with ankylosing spondylitis treated with TNF blockersover 8 years
-
abstract 526
-
Baraliakos X, Fritz C, Listing J, et al. Evaluation of the newASAS instrument to assess disease activity, the ASDAS, in patients with ankylosing spondylitis treated with TNF blockersover 8 years. In: 2010 Annual Scientific Meeting of the American College of Rheumatology (ACR); abstract 526.
-
2010 Annual Scientific Meeting of the American College of Rheumatology (ACR)
-
-
Baraliakos, X.1
Fritz, C.2
Listing, J.3
-
17
-
-
79958864117
-
Evaluation of the New Ankylosing Spondylitis Disease Activity Score (ASDAS) to assess disease activity in patient with active non-radiographic axial spondyloarthritis treated with adalimumab and retreated after interruption of therapy and flare
-
abstract 1938
-
Haibel H, Heldmann F, Listing J, et al. Evaluation of the New Ankylosing Spondylitis Disease Activity Score (ASDAS) to assess disease activity in patient with active non-radiographic axial spondyloarthritis treated with adalimumab and retreated after interruption of therapy and flare. In: 2010 Annual Scientific Meeting of the American College of Rheumatology (ACR); abstract 1938.
-
2010 Annual Scientific Meeting of the American College of Rheumatology (ACR)
-
-
Haibel, H.1
Heldmann, F.2
Listing, J.3
-
18
-
-
79958780201
-
Clinical improvement with etanercept versus sulfasalazine treatment in patients with Ankylosing Spondylitis: Comparative Performance of Various Efficacy Measurements (ASCEND)
-
abstract 1927
-
Van der Heijde D, Braun J, Dougados M, et al. Clinical improvement with etanercept versus sulfasalazine treatment in patients with Ankylosing Spondylitis: Comparative Performance of Various Efficacy Measurements (ASCEND). In: 2010 Annual Scientific Meeting of the American College of Rheumatology (ACR); abstract 1927.
-
2010 Annual Scientific Meeting of the American College of Rheumatology (ACR)
-
-
Van Der Heijde, D.1
Braun, J.2
Dougados, M.3
-
20
-
-
77954964488
-
Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis
-
Poddubnyy DA, Rudwaleit M, Listing J, et al. Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis. Ann Rheum Dis 2010; 69:1338-1341.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1338-1341
-
-
Poddubnyy, D.A.1
Rudwaleit, M.2
Listing, J.3
-
22
-
-
0031990046
-
The OMERACT filter for outcome measures in rheumatology
-
Boers M, Brooks P, Strand CV, et al. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998; 25:198-199.
-
(1998)
J Rheumatol
, vol.25
, pp. 198-199
-
-
Boers, M.1
Brooks, P.2
Strand, C.V.3
|